-
1دورية أكاديمية
المؤلفون: Victoria Federico Paly, Murat Kurt, Lirong Zhang, Marcus O. Butler, Olivier Michielin, Adenike Amadi, Emma Hernlund, Helen M. Johnson, Srividya Kotapati, Andriy Moshyk, John Borrill
المصدر: MDM Policy & Practice, Vol 7 (2022)
مصطلحات موضوعية: Medicine (General), R5-920
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2381-4683
-
2دورية أكاديمية
المؤلفون: Kabirraaj Toor, Mark R. Middleton, Keith Chan, Adenike Amadi, Andriy Moshyk, Srividya Kotapati
المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
مصطلحات موضوعية: Adjuvant treatment, Systematic literature review, Network meta-analysis, Nivolumab, Efficacy, Safety, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1471-2407
-
3دورية أكاديمية
المؤلفون: Bruno Bregman, Siguroli Teitsson, Isabella Orsini, François-Emery Cotté, Adenike Amadi, Andriy Moshyk, Stéphane Roze, Anne-Françoise Gaudin
المصدر: Dermatology and Therapy, Vol 10, Iss 6, Pp 1331-1343 (2020)
مصطلحات موضوعية: Adjuvant melanoma, Cost-effectiveness, France, Nivolumab, Dermatology, RL1-803
وصف الملف: electronic resource
-
4دورية أكاديمية
المؤلفون: Dirk Schadendorf, Mark Middleton, Jeffrey Weber, Delphine Hennicken, Paolo Ascierto, Andriy Moshyk, Roberto Zoffoli, Anne Pieters, Adenike Amadi, Katrin Kupas, Srividya Kotapati
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2051-1426
-
5
المؤلفون: Jeffrey S. Weber, Delphine Hennicken, Anne Pieters, Roberto Zoffoli, Dirk Schadendorf, Paolo A. Ascierto, Mark R. Middleton, Andriy Moshyk, Katrin Kupas, Adenike Amadi, Srividya Kotapati
المصدر: European Journal of Cancer. 158:225-233
مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Adolescent, Population, Medizin, Ipilimumab, Placebo, Disease-Free Survival, Young Adult, Antineoplastic Agents, Immunological, Internal medicine, medicine, Humans, education, Melanoma, Aged, Neoplasm Staging, Aged, 80 and over, education.field_of_study, business.industry, Hazard ratio, Antibodies, Monoclonal, Cancer, Middle Aged, medicine.disease, Confidence interval, Nivolumab, Female, Neoplasm Recurrence, Local, business, medicine.drug
-
6
المؤلفون: Adenike Amadi, Siguroli Teitsson, Anne-Françoise Gaudin, Stéphane Roze, Isabella Orsini, B. Bregman, François-Emery Cotté, Andriy Moshyk
المصدر: Dermatology and Therapy, Vol 10, Iss 6, Pp 1331-1343 (2020)
Dermatology and Therapyمصطلحات موضوعية: Oncology, medicine.medical_specialty, Cost effectiveness, Subgroup analysis, Dermatology, Pembrolizumab, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Medicine, Survival analysis, Original Research, Trametinib, Cost–utility analysis, business.industry, Adjuvant melanoma, Dabrafenib, Nivolumab, RL1-803, 030220 oncology & carcinogenesis, Cost-effectiveness, France, business, medicine.drug
-
7دورية أكاديمية
المؤلفون: Rachael Batteson, Rose Hart, Matthew Hemstock, Kyna Gooden, Srividya Kotapati, Stephane Roze, Dawn Lee, Adenike Amadi
المصدر: Springer, PharmacoEconomics - Open. 4(2):343-351
-
8
المؤلفون: Rachael Batteson, Stéphane Roze, Kyna Gooden, Srividya Kotapati, Rose Hart, Matthew Hemstock, Adenike Amadi, Dawn Lee
المصدر: PharmacoEconomics Open
مصطلحات موضوعية: Pharmacology, Oncology, medicine.medical_specialty, business.industry, Health Policy, medicine.medical_treatment, Melanoma, Ipilimumab, Disease, medicine.disease, Placebo, medicine.anatomical_structure, Internal medicine, medicine, Pharmacology (medical), Original Research Article, Nivolumab, business, Lymph node, Adjuvant, Survival analysis, medicine.drug
-
9
المؤلفون: Victoria Federico Paly, Murat Kurt, Lirong Zhang, Marcus O. Butler, Olivier Michielin, Adenike Amadi, Emma Hernlund, Helen M. Johnson, Srividya Kotapati, Andriy Moshyk, John Borrill
المصدر: MDM policy & practice, vol. 7, no. 1, pp. 23814683221089659
مصطلحات موضوعية: advanced melanoma, immune checkpoint inhibitor, immuno-oncology, ipilimumab, nivolumab, survival heterogeneity, survival modeling, Health Policy, Public Health, Environmental and Occupational Health
وصف الملف: application/pdf
-
10